Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$564M Buy
2,677,710
+84,798
+3% +$18.2M 1.94% 17
2026
Q1
$573M Buy
2,592,912
+343,401
+15% +$84M 2.42% 13
2025
Q4
$570M Buy
2,249,511
+120,200
+6% +$30.2M 2.39% 13
2025
Q3
$527M Buy
2,129,311
+29,212
+1% +$6.99M 2.26% 14
2025
Q2
$504M Buy
2,100,099
+556,088
+36% +$129M 2.45% 14
2025
Q1
$350M Buy
+1,544,011
New +$340M 2% 16

Other funds holding STE

Orbis Allan Gray's STE Position: Q2 2026 in Review

Orbis Allan Gray increased its Steris (STE) stake by 3.3% in Q2 2026, buying an estimated $18.2M and bringing the position to 2,677,710 shares worth $564M. The position accounts for 1.94% of the portfolio, ranked #17.

Orbis Allan Gray first reported a position in STE in Q1 2025 and has held it in 6 quarters since. The position peaked at $573M in Q1 2026. 833 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Orbis Allan Gray held 2,677,710 shares of Steris worth $564M as of Q2 2026.
  • Orbis Allan Gray bought 84,798 Steris shares in Q2 2026, an estimated $18.2M.
  • Steris made up 1.94% of Orbis Allan Gray's portfolio in Q2 2026, its #17 holding.
  • Orbis Allan Gray first reported a position in Steris in Q1 2025 and has held it in 6 quarters since.
  • Orbis Allan Gray's Steris position peaked at $573M in Q1 2026.
  • 833 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Orbis Allan Gray's 13F filing for Q2 2026, filed 14 Aug 2026.